Published in Women's Health Weekly, July 3rd, 1995
Results of this finding was reported at the General Motors Cancer Research Foundation Conference, held June 20-21, 1995, in Bethesda, Maryland.
The diagnostic test, developed by David Sidransky, M.D., and his team at Johns Hopkins Oncology Center in Baltimore, Maryland, identifies cancerous cells in people by matching the genetic fingerprints of those cells with a known line-up of clonal markers - junk pieces of repetitive DNA that serve as a calling card for a specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.